AID RECRUITMENT

Targeting of DNA deaminase AID via transcription and the RNA pol II elongation complex

 Coordinatore IFOM FONDAZIONE ISTITUTO FIRC DI ONCOLOGIA MOLECOLARE 

 Organization address address: "Via Adamello, 16"
city: MILAN
postcode: 20139

contact info
Titolo: Mr.
Nome: Carlo
Cognome: Raimondi Cominesi
Email: send email
Telefono: +39 02 574303256
Fax: +39 02 574303231

 Nazionalità Coordinatore Italy [IT]
 Totale costo 179˙584 €
 EC contributo 179˙584 €
 Programma FP7-PEOPLE
Specific programme "People" implementing the Seventh Framework Programme of the European Community for research, technological development and demonstration activities (2007 to 2013)
 Code Call FP7-PEOPLE-2010-IEF
 Funding Scheme MC-IEF
 Anno di inizio 2011
 Periodo (anno-mese-giorno) 2011-03-01   -   2013-02-28

 Partecipanti

# participant  country  role  EC contrib. [€] 
1    IFOM FONDAZIONE ISTITUTO FIRC DI ONCOLOGIA MOLECOLARE

 Organization address address: "Via Adamello, 16"
city: MILAN
postcode: 20139

contact info
Titolo: Mr.
Nome: Carlo
Cognome: Raimondi Cominesi
Email: send email
Telefono: +39 02 574303256
Fax: +39 02 574303231

IT (MILAN) coordinator 179˙584.00

Mappa


 Word cloud

Esplora la "nuvola delle parole (Word Cloud) per avere un'idea di massima del progetto.

effect    pathologies    complexes    ig    vivo    deamination    genetic    pol    aid    transcription    candidates    containing    dna    instability    diversification    rna    direct    inducing    modification    molecular    chromatin    cell    cytosine    immune    cells    chip    epigenetics    modifications    implicated   

 Obiettivo del progetto (Objective)

'In B cells, antibody repertoire is created via two DNA instability complexes, one of which uses DNA cytosine deamination and is needed for immunoglobulin (Ig) diversification. Targeting of DNA deamination is poorly understood and mis-targeting can lead to genetic pathologies. Activation induced deaminase (AID) catalyses the hydrolytic deamination of cytosine residues, with the resulting uracil inducing DNA instability leading to Ig diversification. Recently AID has been implicated in inducing developmental DNA demethylation and pluripotent stem cell formation. Although transcription had been implicated in these mechanism, no direct evidence existed linking AID activity and transcription. The aim of this application is the analysis of AID containing transcription complexes and the role of RNA pol II modification during Ig diversification and epigenetics. Proteomic analysis of AID containing complexes from cytoplasm, nucleoplasm and chromatin revealed distinct associations, with the chromatin complex containing subunits of the elongating RNA pol II, transcription elongation and chromatin remodelling complexes. Biochemical analysis in vitro and in cell lines will identify direct interactions and domains and subsequent in vivo reconstitution of AID mutants determining in vivo relevance. Genetic analysis of candidates using transgene and knockout in cells and mice will delineate the molecular pathways of how transcription can alter the targeting or efficiency of AID. To further determine the role of the candidates on the loci, various forms of ChIP analysis will be utilised (e.g. double ChIP & ChIP-Seq); including the effect of RNA pol II modification, chromatin markers, and associated factors. Conclusions of this study will provide novel and detailed insight into the molecular mechanisms of AID regulation and how this will effect immune diversification and epigenetics, while providing new drug targets for AID pathologies (i.e. cancer and autoimmunity).'

Introduzione (Teaser)

DNA modifications are a necessary part of adaptive immunity. The AID RECRUITMENT project studied fundamentals of DNA modifications in the human immune system.

Altri progetti dello stesso programma (FP7-PEOPLE)

LCFRI (2008)

Connections between algorithmic and geometric properties of groups

Read More  

REHABNET (2012)

REHABNET: NEUROSCIENCE BASED INTERACTIVE SYSTEMS FOR MOTOR REHABILITATION

Read More  

IMETI (2008)

Implementation of Membrane Technology to Industry

Read More